Welcome. Learn how OneTouch® products and digital solutions can help you have more meaningful conversations with your patients to drive better blood glucose management decisions.
Explore how OneTouch Reveal® Digital Solutions and the OneTouch Verio Reflect® meter can support your virtual care practice.
The OneTouch Verio Reflect® meter and the OneTouch Reveal® mobile app:
Provide patients with greater understanding in managing their blood sugar, so they can confidently make progress towards diabetes goals.
Could help patients feel more motivated to improve their blood sugar levels.*
ColorSure® technology could make it easy to teach patients how to interpret their blood glucose results.
In a market research study, healthcare professionals agreed that the OneTouch Reveal® web app reveals meaningful insights to help them and their patients take the right actions for better blood glucose management.**
* Compared to using a meter without a Blood Sugar Mentor™ feature. Based on a UK 2018 Survey in a simulated model of the OneTouch Verio Reflect® meter and the OneTouch Reveal® mobile app, 78 % of 133 patients agreed.
** In a 2020 online marketing study conducted in France, Germany and the U.S. of 451 endocrinologists and diabetes nurses using a simulated version of the OneTouch Reveal® web app, 82.3 % agreed.
Market availability and product selection vary per country. Please check your local markets. If you require a demo or further information in another language, please submit a request and a OneTouch® Representative will be in contact.
© 2021 LifeScan IP Holdings, LLC. All rights reserved. Trademarks are used under license by LifeScan IP Holdings, LLC.
The third-party trademarks used herein are trademarks of their respective owners. US-OTB-2100042
LifeScan Diabetes Institute launched in 2007 as a global HCP training resource to transform diabetes care. We train healthcare providers to utilize digital diabetes management as the foundation to manage glucose data, clinical interventions, and self-care.
Featured content for ADA attendees includes:
Improving Diabetes Quality of Life by Increasing time in Range
Stopping Clinical Inertia in its Track: A Hypoglycemia Story of Change
BGM compendium published
BGM compendium pro tips
On-Demand Continuing Education Opportunity: Application of Discovery Learning Techniques to Maximize Adoption of Healthy Eating Strategies
Invite to join the LifeScan Diabetes Institute
We invite you to join our website and gain access to exciting learning opportunities in the categories of glucose management, self-care behaviors, complications, and telehealth.
Improved Self-Management and Glycemic Outcomes in Refractory Patients using an Individualized Self-Management Education Strategy
Satisfaction of Healthcare Professionals and People with Diabetes with an Insulin Bolus Calculator Mobile Application
**Visit the Diabetes Learning Bytes on our booth to learn more
Remote Health Consultations Supported by a Diabetes Management Web Application With a New Glucose Meter Demonstrates Improved Glycemic Control
A Comprehensive Evaluation of a Novel Color Range Indicator in Multiple Blood Glucose Meters Demonstrates Improved Glucose Range Interpretation and Awareness in Subjects With Type 1 and Type 2 Diabetes
Interactive Digital Health: Engaging Healthy Behaviors & Clinical Outcomes
No Evidence of Interference and Robust Accuracy of OneTouch Verio® Test Strips Irrespective of Medication Status Study Summary
Revealing the right information at the right time, to the right people.
OneTouch Reveal® web app helps see what’s working and not working for your patients.
Insulin Mentor™ leaflet
* In a 2020 market research study conducted in France, Germany, and the U.S. using a simulated version of the OneTouch Reveal® web app, 84.7% (395 out of 451) of endocrinologists and diabetes nurses surveyed, agreed.
** In a 2020 market research study conducted in France, Germany, and the U.S. using a simulated version of the OneTouch Reveal® web app, 83.1 % and 82.3 %, respectively, of 451 endocrinologists and diabetes nurses surveyed agreed.
The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc., and any use of such marks by LifeScan Scotland Ltd. and its affiliates is under license. Other trademarks and trade names are those of their respective owners.
In a market research study, the OneTouch Verio Reflect® meter was the top preference of healthcare professionals among 4 selected meters, at helping patients engage in their diabetes management so they can meet the goals they set with their healthcare professional.*
In a market research study, patients agreed that with the OneTouch Verio Reflect® system they feel more confident in knowing how to deal with blood glucose excursions the way their HCP recommends.**
Market Research Study on HCP Perceptions of BGM Features
New BGM Features Show Improved Patient Interpretation and Willingness to Act
OneTouch Verio Reflect® meter HCP and Patient Market Research Studies
Introducing the OneTouch Verio Reflect® meter
* 267 (76%) of 353 healthcare professionals surveyed selected the OneTouch Verio Reflect® meter as their preferred choice, based on a comparison to simulated unbranded meter screen images of Accu-Chek® Guide, Contour® Next One and FreeStyle Lite. LifeScan study conducted in Canada, France, Germany, Italy and U.S., in 2019.
**Based on a 2020 clinical study of 133 patients with diabetes shown animated demonstrations of OneTouch Verio Reflect® meter features.
Sign up to receive the latest product news and diabetes related information.
©2021 LifeScan IP Holdings, LLC. All rights reserved. Trademarks are used under license by LifeScan IP Holdings, LLC.
The third party trademarks used herein are trademarks of their respective owners. US-OTB-2000062.
Our vision is to create a world without limits for people with diabetes, their loved ones and care teams.
For more than 40 years LifeScan has advanced glucose management and diabetes care with pioneering technologies and new products defined by simplicity, accuracy and trust.
From OneTouch® brand blood glucose meters, test strips, and lancets to an integrated digital health platform and hospital point-of-care systems, LifeScan is committed to engaging people and providers with wellness insights that motivate healthy living.
Through partnerships with industry leaders, we will usher in the next wave of personalized health and wellness experiences that engage people with diabetes and related conditions to live their best lives.
We accomplish our vision by living Our Shared Values of Care, Create, Connect and Compete. These values guide our actions and are the cornerstone of all that we do.
Dr. Holt attended Duke University and earned her MD degree at Wake Forest University. She is board certified in Endocrinology, and practiced general Endocrinology for many years in Raleigh, NC. Dr. Holt then transitioned to the pharmaceutical industry in Medical Affairs. She is currently Head of Global Clinical, Medical, and Safety at LifeScan.
Additional roles include Assistant Consulting Professor of Medicine at Duke University School of Medicine, Co-Director for Taking Control of Your Diabetes, and Board of Directors for American Association of Clinical Endocrinologists.
She has been named 5 times as one of America’s Top Physicians, has received a Patient’s Choice award 4 times, was named 3 times as Top Endocrinologist, has received a Top Doctor award, and was given a Lifetime Achievement Award from Who’s Who.
Dr. Juan Pablo Frias is Medical Director and Principal Investigator of National Research Institute in Los Angeles, CA. He received his medical degree from Vanderbilt University School of Medicine and completed his Fellowship in Endocrinology, Diabetes and Metabolism at the University of California, San Diego. Dr. Frías has held academic positions at the University of Colorado Health Sciences Center, Barbara Davis Center for Diabetes, and the University of California San Diego School of Medicine. He has been involved in diabetes and metabolism-related research for over 25 years and has authored numerous publications in this field.